IRIS Accounts Production v23.3.1.45 06807612 director 1.4.22 31.3.23 31.3.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068076122022-03-31068076122023-03-31068076122022-04-012023-03-31068076122021-03-31068076122021-04-012022-03-31068076122022-03-3106807612ns10:Originalns15:EnglandWales2022-04-012023-03-3106807612ns14:PoundSterlingns10:Original2022-04-012023-03-3106807612ns10:Originalns10:Director12022-04-012023-03-3106807612ns10:Original2022-04-012023-03-3106807612ns10:Original2023-03-3106807612ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3106807612ns10:Originalns10:SmallEntities2022-04-012023-03-3106807612ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3106807612ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3106807612ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3106807612ns10:Originalns10:FullAccounts2022-04-012023-03-3106807612ns10:Original12022-04-012023-03-3106807612ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3106807612ns10:Originalns10:RegisteredOffice2022-04-012023-03-3106807612ns10:Original2022-03-3106807612ns10:Originalns5:CurrentFinancialInstruments2023-03-3106807612ns10:Originalns5:CurrentFinancialInstruments2022-03-3106807612ns10:Originalns5:Non-currentFinancialInstruments2023-03-3106807612ns10:Originalns5:Non-currentFinancialInstruments2022-03-3106807612ns5:ShareCapitalns10:Original2023-03-3106807612ns5:ShareCapitalns10:Original2022-03-3106807612ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3106807612ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3106807612ns10:Originalns5:NetGoodwill2022-04-012023-03-3106807612ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3106807612ns10:Originalns5:FurnitureFittings2022-04-012023-03-3106807612ns10:Originalns5:ComputerEquipment2022-04-012023-03-3106807612ns10:Original2021-04-012022-03-3106807612ns10:Originalns5:NetGoodwill2022-03-3106807612ns10:Originalns5:NetGoodwill2023-03-3106807612ns10:Originalns5:NetGoodwill2022-03-3106807612ns10:Originalns5:FurnitureFittings2022-03-3106807612ns10:Originalns5:ComputerEquipment2022-03-3106807612ns10:Original2022-03-3106807612ns10:Originalns5:FurnitureFittings2023-03-3106807612ns10:Originalns5:ComputerEquipment2023-03-3106807612ns10:Originalns5:FurnitureFittings2022-03-3106807612ns10:Originalns5:ComputerEquipment2022-03-3106807612ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106807612ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3106807612ns10:Originalns5:WithinOneYear2023-03-3106807612ns10:Originalns5:WithinOneYear2022-03-3106807612ns5:BetweenOneFiveYearsns10:Original2023-03-3106807612ns5:BetweenOneFiveYearsns10:Original2022-03-3106807612ns10:Originalns5:AllPeriods2023-03-3106807612ns10:Originalns5:AllPeriods2022-03-3106807612ns10:Originalns10:OrdinaryShareClass12023-03-3106807612ns10:Original1ns10:Director12022-03-3106807612ns10:Original1ns10:Director12021-03-3106807612ns10:Original1ns10:Director12022-04-012023-03-3106807612ns10:Original1ns10:Director12021-04-012022-03-3106807612ns10:Original1ns10:Director12023-03-3106807612ns10:Original1ns10:Director12022-03-31
REGISTERED NUMBER: 06807612 (England and Wales)











ADVENIUNT MEDICAL INTERNATIONAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2023






ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023










Page

Company Information 1

Statement of Financial Position 2 to 3

Notes to the Financial Statements 4 to 7


ADVENIUNT MEDICAL INTERNATIONAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2023







DIRECTOR: H A R D Atchia





REGISTERED OFFICE: 20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE





REGISTERED NUMBER: 06807612 (England and Wales)





ACCOUNTANTS: Gibbons Mannington & Phipps LLP
Chartered Accountants
20 Eversley Road
Bexhill-on-Sea
East Sussex
TN40 1HE

ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

STATEMENT OF FINANCIAL POSITION
31ST MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 15,820 21,591
15,820 21,591

CURRENT ASSETS
Debtors 6 1,178,878 1,086,230
Cash at bank 5,514 11,846
1,184,392 1,098,076
CREDITORS
Amounts falling due within one year 7 635,632 674,218
NET CURRENT ASSETS 548,760 423,858
TOTAL ASSETS LESS CURRENT
LIABILITIES

564,580

445,449

CREDITORS
Amounts falling due after more than
one year

8

(239,485

)

(39,691

)

PROVISIONS FOR LIABILITIES (3,955 ) (5,398 )
NET ASSETS 321,140 400,360

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 321,040 400,260
SHAREHOLDERS' FUNDS 321,140 400,360

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

STATEMENT OF FINANCIAL POSITION - continued
31ST MARCH 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29th February 2024 and were signed by:





H A R D Atchia - Director


ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023


1. STATUTORY INFORMATION

Adveniunt Medical International Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2009, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings and equipment - 15% on reducing balance
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2022 - 18 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st April 2022
and 31st March 2023 17,497
AMORTISATION
At 1st April 2022
and 31st March 2023 17,497
NET BOOK VALUE
At 31st March 2023 -
At 31st March 2022 -

5. TANGIBLE FIXED ASSETS
Fixtures,
fittings
and Computer
equipment equipment Totals
£    £    £   
COST
At 1st April 2022 14,611 60,040 74,651
Additions - 1,055 1,055
At 31st March 2023 14,611 61,095 75,706
DEPRECIATION
At 1st April 2022 10,736 42,324 53,060
Charge for year 582 6,244 6,826
At 31st March 2023 11,318 48,568 59,886
NET BOOK VALUE
At 31st March 2023 3,293 12,527 15,820
At 31st March 2022 3,875 17,716 21,591

ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 497,926 537,180
Other debtors 680,952 549,050
1,178,878 1,086,230

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 11,092 10,414
Trade creditors 66,229 61,760
Taxation and social security 372,447 414,848
Other creditors 185,864 187,196
635,632 674,218

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 30,856 39,691
Other creditors 208,629 -
239,485 39,691

9. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2023 2022
£    £   
Within one year 47,500 47,500
Between one and five years 110,833 158,333
158,333 205,833

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

ADVENIUNT MEDICAL INTERNATIONAL LIMITED (REGISTERED NUMBER: 06807612)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2023 and 31st March 2022:

2023 2022
£    £   
H A R D Atchia
Balance outstanding at start of year 438,596 277,241
Amounts advanced 249,020 313,385
Amounts repaid (174,225 ) (152,030 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 513,391 438,596

The director operates a current account with the company. The balance due from the director as at 31st March 2023 amounted to £513,391.

Interest is charged at 2.00% on amounts owed to the company.

12. RELATED PARTY DISCLOSURES

The director has provided a personal guarantee in respect of the loans included within other creditors, referred to in Notes 8 and 9, above.